Mental health well-being is on every employer's mind in 2021. In today's blog post, we're profiling five popular mental well-being vendors and how data can help self-insured employers evaluate their effectiveness.
Four Ways to Leverage Data to Justify Behavioral Health Programs
CEO and co-founder Grant Gordon is sharing his insights with Employee Benefits News. This piece explores how employers can find problems, track solutions, and prove ROI on behavioral health wellness programs using data.
How Working with PBMs Can Help Control Your Pharmacy Spend
Artemis Health is in the news. Our Chief Clinical Officer Rance Hutchings, Pharm.D., is sharing his tips and tricks for working with Pharmacy Benefit Managers. Check out his piece for Workforce.com and learn what questions you should be asking to get the most from your Rx spending.
What’s the Cost of a Severe Peanut Allergy?
It’s that time of year again—the time of year when moms and dads around the country send their little angels back to school. Some of you are celebrating, and some of you are wistfully thinking about how fast they grow up. And there’s a good chance some of you are looking for lunch ideas that don’t include peanut butter sandwiches.
How Specialty Drugs Affect Your Rx Spend (And What You Can Do About It)
Experts are estimating that specialty Rx will account for 50% of total spending by 2018. Let’s take a closer look at this segment of spending and how employers can help stop the rising tide.
Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data
Artemis Health received $16 million in Series B funding led by F-Prime Capital (the venture capital funds of FMR LLC, the parent company of Fidelity Investments), with participation from previous investors Maverick Ventures and Kickstart Seed Fund. This is the second major round of funding Artemis Health has raised in 12 months.